Company Research Report: Reactive Robotics GmbH

Company Overview

• Name: Reactive Robotics GmbH

• Mission: Set the new gold standard for early mobilization of critically ill patients using robotic assistance systems.

• Founded: April 2015

• Founders: No information is available.

• Key People:

• Brigitte Schrätzenstaller, Managing Director

• Maximilian Große-Dunker, COO

• Other team members include Max, Antonin, Charlotta, Jan, Maxi, Giovanni, Fabian, and more.

• Headquarters: Landsbergerstr. 234, 80687 Munich, Germany

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Developing robotic assistance systems for early mobilization of critically ill patients, specifically known for the VEMOTION® system.

Products

VEMOTION®

• Product Overview: A robotic assistance system designed to aid in the very early mobilization of intensive care patients directly in their beds.

• Key Features:

• Vertikalisierung: Allows verticalization up to 70 degrees in combination with robotically assisted walking movements.

• Assist-as-Needed (AAN): Supports patient-initiated movements without the need for complex sensors.

• Adaptive Support: Can be personalized according to the patient's physical abilities through manual or auto-adaptive adjustments.

• Digital Recording: Detailed tracking of therapy progress and patient activity, compliant with GDPR.

• Hygienic Standards: All components meet high hygiene standards and are easy to clean.

Recent Developments

• New Products Launched: No new products have been mentioned beyond VEMOTION®.

• New Features Added:

• Enhanced capability for mobilizing patients up to 180 kg / 400 lbs.

• Integration of machine learning tools for improved therapy outcomes.

• Partnerships:

• Engaged in multiple research collaborations such as MobIPaR and MobiStaR projects to enhance robotic mobilization solutions.

• Cooperation with Rechtsdepesche to further explore mobilization concepts.

• Financial Milestones:

• Secured a €5 million funding round for expansion and further development of VEMOTION®.

• Received a €2.5 million grant from the European Innovation Council in 2023.

Additional Information

• VEMOTION® Application:

• Demonstrated success in facilitating early mobilization, particularly beneficial for neurologically impaired patients through patient-initiated movements.

• Approved for use in various clinical settings, undergoing successful implementation in hospitals such as BGU Murnau and Schön Klinik.

• Research Engagements:

• Conducting research with partners like Schön Klinik Bad Aibling and several universities under government-backed projects to validate and enhance clinical applicability.

In conclusion, Reactive Robotics GmbH is at the forefront of developing innovative robotics solutions for patient mobilization, with a strong focus on application in intensive care units to assist healthcare staff and improve patient recovery outcomes.